España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
OptimizeRx
OPRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.42
0
0.00%
Pre-Market: 4:00 PM EDT
Get Report
Comment
OptimizeRx (OPRX) Forecast
News
Earnings
OptimizeRx (OPRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for OptimizeRx (NASDAQ:OPRX) Stock
OptimizeRx Stock (NASDAQ: OPRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
RBC Capital Maintains Outperform on OptimizeR...
Benzinga Newsdesk
Roth MKM Reiterates Buy on OptimizeRx, Lowers...
Benzinga Newsdesk
Stifel Maintains Buy on OptimizeRx, Lowers Pr...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on OptimizeRx...
Benzinga Newsdesk
OptimizeRx shares are trading lower after JMP...
Benzinga Newsdesk
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Wednesday, November 13, 2024
OptimizeRx shares are trading lower after the...
Benzinga Newsdesk
OptimizeRx Q3 2024 Adj. EPS $0.12 Beats $0.06...
Benzinga Newsdesk
OptimizeRx Sees FY2024 Sales $88.000M-92.000M...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2024
Benzinga Insights
Tuesday, November 12, 2024
Preview: OptimizeRx's Earnings
Benzinga Insights
Wednesday, November 06, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tuesday, September 10, 2024
OptimizeRx Reports Expansion Of Strategic Rel...
Benzinga Newsdesk
Monday, September 09, 2024
OptimizeRx Launches Micro-Neighborhood Target...
Benzinga Newsdesk
Friday, August 16, 2024
RBC Capital Maintains Outperform on OptimizeR...
Benzinga Newsdesk
Monday, August 12, 2024
A Closer Look at 5 Analyst Recommendations For OptimizeRx
Benzinga Insights
Barclays Maintains Equal-Weight on OptimizeRx...
Benzinga Newsdesk
Thursday, August 08, 2024
OptimizeRx Reiterates 2024 Guidance And Expec...
Benzinga Newsdesk
OptimizeRx Q2 2024 Adj. EPS $0.02 Beats $(0.0...
Benzinga Newsdesk
Monday, June 24, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Friday, June 21, 2024
Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know
Benzinga Insights
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Wednesday, May 15, 2024
Gold Rises Over 1%; Arcos Dorados Shares Fall After Q1 Results
Avi Kapoor
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Nasdaq Surges 150 Points; Retail Sales Flat For April
Avi Kapoor
OptimizeRx shares are trading higher after th...
Benzinga Newsdesk
Expert Ratings For OptimizeRx
Benzinga Insights
Stifel Maintains Buy on OptimizeRx, Maintains...
Benzinga Newsdesk
Tuesday, May 14, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
OptimizeRx Reiterates FY24 Guidance With Reve...
Benzinga Newsdesk
OptimizeRx Q1 Adj $(0.11) Beats $(0.13) Estim...
Benzinga Newsdesk
Friday, April 26, 2024
OptimizeRx Corporation Says 1Q24 Revenue Expe...
Benzinga Newsdesk
Tuesday, April 16, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
OptimizeRx Sees FY24 Revenue Of $100M Vs. $10...
Benzinga Newsdesk
OptimizeRx Q4 Adj EPS $0.26, Inline, Sales $2...
Benzinga Newsdesk
Thursday, April 04, 2024
JMP Securities Initiates Coverage On Optimize...
Benzinga Newsdesk
Monday, April 01, 2024
Where OptimizeRx Stands With Analysts
Benzinga Insights
Stifel Maintains Buy on OptimizeRx, Maintains...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on Optimize...
Benzinga Newsdesk
Thursday, March 28, 2024
Earnings Scheduled For March 28, 2024
Benzinga Insights
Wednesday, March 27, 2024
OptimizeRx Earnings Preview
Benzinga Insights
Tuesday, March 12, 2024
OptimizeRx shares are trading lower. The comp...
Benzinga Newsdesk
Monday, March 11, 2024
OptimizeRx Reaffirms Prior Revenue In The Range Of $68M-$70M Vs $69.85M Est. And Adjusted EBITDA Estimates For FY2023
Happy Mohamed
Wednesday, January 10, 2024
RBC Capital Maintains Outperform on OptimizeR...
Benzinga Newsdesk
Tuesday, January 09, 2024
OptimizeRx shares are trading higher after th...
Benzinga Newsdesk
OptimizeRx Says Prelim, 2023 Revenue Is Expec...
Benzinga Newsdesk
Wednesday, January 03, 2024
Barclays Initiates Coverage On OptimizeRx wit...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch